It has been claimed that pyoderma gangrenosum (PG) lesions may contain gran
ulomatous foci when associated with Crohn's disease. To test this assertion
, we obtained clinical histories and archived cutaneous biopsies from 34 PG
patients. Thirteen of these patients had inflammatory bowel disease (IBD).
Immunostaining with PGM1, a macrophage marker, revealed well-formed giant
cells with three or more nuclei in biopsies from 6 of 13 patients with IBD.
Five of the 6 biopsies came from patients with Crohn's disease and one fro
m a patient with ulcerative colitis. Two were peristomal. In the 21 patient
s who had PG without IBD, no giant cells were seen. Thus, PGM1 + histiocyti
c giant cells within a PG lesion may be indicative of associated IBD (p=0.0
06), particularly Crohn's disease.